snp cyp2c19 c 469857 10 (Thermo Fisher)
Thermo Fisher is a verified supplier 
Thermo Fisher manufactures this product 
86
Structured Review
Thermo Fisher
snp cyp2c19 c 469857 10
Snp Cyp2c19 C 469857 10, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/snp+cyp2c19+c+469857+10/SNP+CYP2C19%2C+C____469857_10/pm41028360-203-16--1
Average 86 stars, based on 1 article reviews
Snp Cyp2c19 C 469857 10, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/snp+cyp2c19+c+469857+10/SNP+CYP2C19%2C+C____469857_10/pm41028360-203-16--1
Average 86 stars, based on 1 article reviews
snp cyp2c19 c 469857 10 - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
other:Article Title: Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis Article Snippet: , rs12248560 , *17 , C____469857_10 , NG_008384.3:g.4220C>T. Article Title: Integrative pharmacogenomics analysis predicts the platelet response in clopidogrel treated coronary artery disease (CAD) patients of South India Article Snippet: The following TaqMan SNP genotyping assays were used in this study: C__25986767_70 ( CYP2C19 *2- rs4244285), C__27861809_10 ( CYP2C19 *3-rs4986893), C_469857_10 ( CYP2C19 *17- rs12248560), C__26201900_30 ( CYP3A4 - rs2242480), C_7586657_20 ( ABCB1- rs1045642), C__2548962_20 ( PON1 -rs662), C__1941752_10 ( P2RY12 - rs2046934), C__25940258_10 ( P2RY12- rs3732759), C__25472353_10 ( P2RY12- rs6785930), C__31527835_20 ( P2RY12 - rs6787801), C__31527835_20 ( P2RY12 - rs31527835_20), C_25640992_10 ( P2RY12 - rs6809699), C__11733842_20 ( B4GALT2 - rs106 SNP. Article Title: Impact of CYP2C19 metabolizer status on esophageal mucosal inflammation, acid exposure, and motility among patients on chronic proton-pump inhibitor therapy with refractory symptoms of gastroesophageal reflux disease Article Snippet: Genotyping was assessed using Article Title: Integrative pharmacogenomics analysis predicts the platelet response in clopidogrel treated coronary artery disease (CAD) patients of South India. Article Snippet: The following TaqMan SNP genotyping assays were used in this study: C__25986767_70 (CYP2C19*2- rs4244285), C__27861809_10 (CYP2C19*3-rs4986893), C_469857_10 (CYP2C19*17rs12248560), C__26201900_30 (CYP3A4- rs2242480), C_7586657_20 (ABCB1- rs1045642), C__2548962_20 (PON1-rs662), C__1941752_10 (P2RY12- rs2046934), C__25940258_10 (P2RY12-rs3732759), C__25472353_10 (P2RY12- rs6785930), C__31527835_20 (P2RY12- rs6787801), C__31527835_20 (P2RY12- rs31527835_20), C_25640992_10 (P2RY12- rs6809699), C__11733842_20 (B4GALT2- rs106 SNP. Article Title: Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing. Article Snippet: For CYP2C19 genotyping, TaqMan Drug Metabolism Enzyme (DME) Genotyping Assays were used to detect the following SNPs in CYP2C19: *2 (c.681G > A, SNP ID rs4244285), *3 (c.636G > A, SNP ID rs4986893), and *17 (c.-806C > T, SNP ID rs12248560) alleles (Assay ID Variant Assay:Article Title: CYP2B6 and ABCB1 genotypes predict methadone plasma exposure among patients on maintenance therapy against opioid addictions in Tanzania. Article Snippet: Genomic DNA was isolated from peripheral leukocytes using QIAamp DNA Midi Kit (Qiagen GmbH, Hilden, Germany). .. Genotyping for the common variant alleles for CYP3A4(*1B), CYP3A5 (*3, *6, *7), CYP2A6(*9), CYP2B6 (*6, *18), CYP2C19 (*2, *3, *17), CYP2D6 (*2, *4, *10, *17), ABCB1 (C3435>T, c.4036A>G), UGT2B7 (372G>A) and SLCO1B1 (*1B, *5) relevant for methadone disposition was performed using the TaqMan drug metabolism genotyping assays (Applied Biosystems, Waltham, MA, USA) as described previously.27–29 The following SNP ID numbers were used C_7817765_60 for CYP2B6*6 (rs3745274), C_60732328_20 for CYP2B6*18 (rs28399499), C_27102425_10 for CYP2D6*2 (rs 16 947), C_27102431_D0 for CYP2D6*4 (rs3892097), C_11484460_40 for CYP2D6*10 (rs1065852), C_2222771_A0 for CYP2D6*17 (rs28371706), C_30634332_10 for CYP2A6*9 (rs28399433), C_1837671_50 for CYP3A4*1B (rs2740574), C_26201809_30 for CYP3A5*3 (rs776746), C_30203950_10 for CYP3A5*6 (rs10264272), C_32287188_10 for CYP3A5*7 (rs41303343), C_25986767_70 for CYP2C19*2 (rs4244285), C_27861809_10 for CYP2C19*3 (rs4986893), TaqMan Allelic Discrimination Assay:Article Title: Genetic polymorphisms of CYP2C19 in ecuadorian population: An interethnic approach Article Snippet: .. In order to validate the method, all carriers of the T allele (heterozygotes and homozygotes) and 20 homozygotes of the C allele were confirmed by the specific TaqMan Allelic Discrimination Assay (Applied Biosystems, Foster City, CA, USA) |